キッセイ薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/09/29 | 3,400 | 3,415 | 3,375 | 3,390 | ±0 | ±0% | 63,900 |
2023/09/28 | 3,400 | 3,430 | 3,370 | 3,390 | -60 | -1.7% | 48,700 |
2023/09/27 | 3,405 | 3,465 | 3,360 | 3,450 | +40 | +1.2% | 93,100 |
2023/09/26 | 3,420 | 3,440 | 3,390 | 3,410 | -25 | -0.7% | 48,400 |
2023/09/25 | 3,405 | 3,470 | 3,400 | 3,435 | +50 | +1.5% | 59,000 |
2023/09/22 | 3,390 | 3,410 | 3,350 | 3,385 | -15 | -0.4% | 54,400 |
2023/09/21 | 3,410 | 3,450 | 3,390 | 3,400 | +5 | +0.1% | 62,400 |
2023/09/20 | 3,475 | 3,485 | 3,395 | 3,395 | -65 | -1.9% | 88,300 |
2023/09/19 | 3,480 | 3,485 | 3,435 | 3,460 | -45 | -1.3% | 81,700 |
2023/09/15 | 3,495 | 3,535 | 3,465 | 3,505 | +40 | +1.2% | 108,400 |
2023/09/14 | 3,455 | 3,470 | 3,415 | 3,465 | +15 | +0.4% | 60,700 |
2023/09/13 | 3,435 | 3,475 | 3,425 | 3,450 | +15 | +0.4% | 64,900 |
2023/09/12 | 3,385 | 3,460 | 3,385 | 3,435 | +75 | +2.2% | 94,300 |
2023/09/11 | 3,410 | 3,435 | 3,340 | 3,360 | -40 | -1.2% | 51,000 |
2023/09/08 | 3,370 | 3,455 | 3,355 | 3,400 | +45 | +1.3% | 128,600 |
2023/09/07 | 3,390 | 3,395 | 3,350 | 3,355 | -45 | -1.3% | 38,600 |
2023/09/06 | 3,420 | 3,425 | 3,395 | 3,400 | -25 | -0.7% | 24,700 |
2023/09/05 | 3,440 | 3,445 | 3,395 | 3,425 | -20 | -0.6% | 55,300 |
2023/09/04 | 3,470 | 3,475 | 3,405 | 3,445 | -5 | -0.1% | 67,600 |
2023/09/01 | 3,390 | 3,470 | 3,390 | 3,450 | +40 | +1.2% | 75,100 |
2023/08/31 | 3,370 | 3,430 | 3,370 | 3,410 | +50 | +1.5% | 78,200 |
2023/08/30 | 3,285 | 3,390 | 3,285 | 3,360 | +15 | +0.4% | 111,000 |
2023/08/29 | 3,355 | 3,420 | 3,330 | 3,345 | -80 | -2.3% | 94,900 |
2023/08/28 | 3,380 | 3,445 | 3,380 | 3,425 | +50 | +1.5% | 80,900 |
2023/08/25 | 3,385 | 3,410 | 3,370 | 3,375 | -60 | -1.7% | 47,900 |
2023/08/24 | 3,450 | 3,460 | 3,430 | 3,435 | -25 | -0.7% | 23,600 |
2023/08/23 | 3,450 | 3,485 | 3,430 | 3,460 | -10 | -0.3% | 29,200 |
2023/08/22 | 3,380 | 3,470 | 3,375 | 3,470 | +50 | +1.5% | 40,600 |
2023/08/21 | 3,420 | 3,450 | 3,380 | 3,420 | ±0 | ±0% | 50,400 |
2023/08/18 | 3,450 | 3,450 | 3,410 | 3,420 | -50 | -1.4% | 34,400 |
2023/08/17 | 3,490 | 3,515 | 3,435 | 3,470 | -45 | -1.3% | 87,900 |
2023/08/16 | 3,480 | 3,540 | 3,480 | 3,515 | -5 | -0.1% | 43,700 |
2023/08/15 | 3,540 | 3,540 | 3,455 | 3,520 | -20 | -0.6% | 95,600 |
2023/08/14 | 3,585 | 3,600 | 3,525 | 3,540 | -35 | -1% | 45,100 |
2023/08/10 | 3,495 | 3,580 | 3,490 | 3,575 | +35 | +1% | 56,700 |
2023/08/09 | 3,520 | 3,580 | 3,510 | 3,540 | +5 | +0.1% | 58,800 |
2023/08/08 | 3,510 | 3,595 | 3,500 | 3,535 | +25 | +0.7% | 94,800 |
2023/08/07 | 3,420 | 3,515 | 3,420 | 3,510 | +105 | +3.1% | 69,500 |
2023/08/04 | 3,440 | 3,440 | 3,385 | 3,405 | -10 | -0.3% | 70,100 |
2023/08/03 | 3,495 | 3,495 | 3,400 | 3,415 | -105 | -3% | 114,100 |
2023/08/02 | 3,520 | 3,555 | 3,480 | 3,520 | +30 | +0.9% | 202,700 |
2023/08/01 | 3,430 | 3,565 | 3,365 | 3,490 | +480 | +15.9% | 416,900 |
2023/07/31 | 3,015 | 3,060 | 3,000 | 3,010 | +44 | +1.5% | 83,300 |
2023/07/28 | 2,943 | 2,966 | 2,922 | 2,966 | -13 | -0.4% | 160,700 |
2023/07/27 | 2,980 | 2,988 | 2,951 | 2,979 | -21 | -0.7% | 52,800 |
2023/07/26 | 2,980 | 3,010 | 2,967 | 3,000 | +6 | +0.2% | 44,000 |
2023/07/25 | 3,060 | 3,060 | 2,980 | 2,994 | -26 | -0.9% | 79,000 |
2023/07/24 | 2,981 | 3,035 | 2,977 | 3,020 | +59 | +2% | 53,100 |
2023/07/21 | 2,957 | 2,974 | 2,937 | 2,961 | +36 | +1.2% | 32,700 |
2023/07/20 | 2,958 | 2,958 | 2,925 | 2,925 | -52 | -1.7% | 49,600 |
401~
450
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「キッセイ薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
キッセイ薬 | 385,500円 | +3.6% | +6.1% | 3.11% | 12.99倍 | 0.76倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
サワイGHD | 188,900円 | +5.9% | +24.5% | 2.91% | 12.53倍 | 1.18倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
ペプチド | 167,300円 | +5.0% | +1.5% | 0.00% | 14.31倍 | 3.81倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
科研薬 | 373,800円 | -6.4% | -71.8% | 5.08% | 41.63倍 | 0.93倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム